NEURODEGENERATIVE DISEASES
Clinical trials for NEURODEGENERATIVE DISEASES explained in plain language.
Never miss a new study
Get alerted when new NEURODEGENERATIVE DISEASES trials appear
Sign up with your email to follow new studies for NEURODEGENERATIVE DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Alzheimer's patients test drug for over a year in extended safety study
Disease control TerminatedThis study aimed to check the long-term safety and effects of an experimental drug called XPro1595 in people with Alzheimer's disease. It was an extension for 11 people who had already taken the drug in an earlier trial. Participants received a weekly injection for up to 18 month…
Matched conditions: NEURODEGENERATIVE DISEASES
Phase: PHASE2 • Sponsor: Inmune Bio, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Brain disease drug trial halted after offering continued treatment
Disease control TerminatedThis study aimed to provide continued access to the experimental drug latozinemab for people with neurodegenerative brain diseases who had already taken it in a previous trial. It was designed to monitor the safety of longer-term treatment. The study was terminated and only enrol…
Matched conditions: NEURODEGENERATIVE DISEASES
Phase: PHASE3 • Sponsor: Alector Inc. • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC